Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot
Germany
Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
<Goal xmlns="http://hl7.org/fhir">
<id value="FollowUpGoal"/>
<meta>
<profile
value="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-goal"/>
</meta>
<language value="de"/>
<text>
<status value="extensions"/>
<div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: Goal FollowUpGoal</b></p><a name="FollowUpGoal"> </a><a name="hcFollowUpGoal"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-onko-therapy-goal.html">Onkologisches Therapieziel</a></p></div><blockquote><p><b>Goal acceptance</b></p><ul><li>individual: <a href="Patient-PatientinMamma.html">Sabine Baumann Female, DoB: 1977-06-24</a></li><li>status: agree</li><li>priority: <span title="Codes:{http://terminology.hl7.org/CodeSystem/goal-priority high-priority}">High Priority</span></li></ul></blockquote><blockquote><p><b>Goal: Related Goal</b></p><ul><li>type: <span title="Codes:{http://hl7.org/fhir/goal-relationship-type predecessor}">Predecessor</span></li><li>target: <a href="Goal-DiagnosticGoal.html">Goal: extension = ; lifecycleStatus = active; achievementStatus = In Progress; category = Diagnostic intent; priority = High Priority; description = ; start[x] = 2025-09-12</a></li></ul></blockquote><blockquote><p><b>Goal: Related Goal</b></p><ul><li>type: <span title="Codes:{http://hl7.org/fhir/goal-relationship-type predecessor}">Predecessor</span></li><li>target: <a href="Goal-TherapiezielMammaHeilung.html">Goal: extension = ,,,; lifecycleStatus = active; achievementStatus = Achieved; category = Heilung,Funktionserhalt; priority = High Priority; description = ; start[x] = 2025-09-22</a></li></ul></blockquote><p><b>lifecycleStatus</b>: Planned</p><p><b>achievementStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/goal-achievement in-progress}">In Progress</span></p><p><b>category</b>: <span title="Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/onko-therapy-goal-type lebensqualitaet}">Lebensqualität</span></p><p><b>priority</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/goal-priority high-priority}">High Priority</span></p><p><b>description</b>: <span title="Codes:">Monitoring der Lebensqualität und des Krankheitsstatus nach der onkologischen Erkrankung und Therapie</span></p><p><b>subject</b>: <a href="Patient-PatientinMamma.html">Sabine Baumann Female, DoB: 1977-06-24</a></p><p><b>start</b>: 2026-08-15</p><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 21976-6}">Cancer outcome status</span></p><p><b>detail</b>: <span title="Codes:">Kein Hinweis auf Lokalrezidiv oder Fernmetastasen</span></p><p><b>due</b>: 2026-11-15</p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 24606-6}">Mammografie</span></p><p><b>detail</b>: <span title="Codes:">Unauffällige Nachsorge-Mammographie (jährlich), kein Rezidivnachweis</span></p><p><b>due</b>: 2027-04-15</p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:">Arm-/Schulterfunktion und Lymphödem-Status nach axillärem Eingriff</span></p><p><b>detail</b>: <span title="Codes:">Kein manifestes Lymphödem, erhaltene Schulterbeweglichkeit</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:">Gesundheitsbezogene Lebensqualität (PROM, EORTC QLQ-C30 / BR23) – MII PRO-Modul</span></p><p><b>detail</b>: <span title="Codes:">Stabile bis verbesserte Lebensqualität im Verlauf</span></p></blockquote><p><b>expressedBy</b>: <a href="Practitioner-OnkologinMamma.html">Practitioner Katrin Musterarzt </a></p><p><b>addresses</b>: <a href="Condition-ConditionMamma.html">Condition Bösartige Neubildung: Oberer äußerer Quadrant der Brustdrüse</a></p><p><b>outcomeReference</b>: <a href="Observation-ObsDiseaseStatusMamma.html">Observation Cancer disease progression</a></p></div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/goal-acceptance">
<extension url="individual">
<valueReference>🔗
<reference value="Patient/PatientinMamma"/>
</valueReference>
</extension>
<extension url="status">
<valueCode value="agree"/>
</extension>
<extension url="priority">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/goal-priority"/>
<code value="high-priority"/>
<display value="High Priority"/>
</coding>
</valueCodeableConcept>
</extension>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/goal-relationship">
<extension url="type">
<valueCodeableConcept>
<coding>
<system value="http://hl7.org/fhir/goal-relationship-type"/>
<code value="predecessor"/>
<display value="Predecessor"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="target">
<valueReference>🔗
<reference value="Goal/DiagnosticGoal"/>
</valueReference>
</extension>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/goal-relationship">
<extension url="type">
<valueCodeableConcept>
<coding>
<system value="http://hl7.org/fhir/goal-relationship-type"/>
<code value="predecessor"/>
<display value="Predecessor"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="target">
<valueReference>🔗
<reference value="Goal/TherapiezielMammaHeilung"/>
</valueReference>
</extension>
</extension>
<lifecycleStatus value="planned"/>
<achievementStatus>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/goal-achievement"/>
<code value="in-progress"/>
<display value="In Progress"/>
</coding>
</achievementStatus>
<category>
<coding>
<system
value="https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/onko-therapy-goal-type"/>
<code value="lebensqualitaet"/>
<display value="Lebensqualität"/>
</coding>
</category>
<priority>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/goal-priority"/>
<code value="high-priority"/>
<display value="High Priority"/>
</coding>
</priority>
<description>
<text
value="Monitoring der Lebensqualität und des Krankheitsstatus nach der onkologischen Erkrankung und Therapie"/>
</description>
<subject>🔗
<reference value="Patient/PatientinMamma"/>
</subject>
<startDate value="2026-08-15"/>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="21976-6"/>
<display value="Cancer outcome status"/>
</coding>
</measure>
<detailCodeableConcept>
<text value="Kein Hinweis auf Lokalrezidiv oder Fernmetastasen"/>
</detailCodeableConcept>
<dueDate value="2026-11-15"/>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="24606-6"/>
<display value="Mammografie"/>
</coding>
</measure>
<detailCodeableConcept>
<text
value="Unauffällige Nachsorge-Mammographie (jährlich), kein Rezidivnachweis"/>
</detailCodeableConcept>
<dueDate value="2027-04-15"/>
</target>
<target>
<measure>
<text
value="Arm-/Schulterfunktion und Lymphödem-Status nach axillärem Eingriff"/>
</measure>
<detailCodeableConcept>
<text
value="Kein manifestes Lymphödem, erhaltene Schulterbeweglichkeit"/>
</detailCodeableConcept>
</target>
<target>
<measure>
<text
value="Gesundheitsbezogene Lebensqualität (PROM, EORTC QLQ-C30 / BR23) – MII PRO-Modul"/>
</measure>
<detailCodeableConcept>
<text value="Stabile bis verbesserte Lebensqualität im Verlauf"/>
</detailCodeableConcept>
</target>
<expressedBy>🔗
<reference value="Practitioner/OnkologinMamma"/>
</expressedBy>
<addresses>🔗
<reference value="Condition/ConditionMamma"/>
</addresses>
<outcomeReference>🔗
<reference value="Observation/ObsDiseaseStatusMamma"/>
</outcomeReference>
</Goal>